1. Home
  2. STNE vs KRYS Comparison

STNE vs KRYS Comparison

Compare STNE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STNE
  • KRYS
  • Stock Information
  • Founded
  • STNE 2012
  • KRYS 2015
  • Country
  • STNE Cayman Islands
  • KRYS United States
  • Employees
  • STNE N/A
  • KRYS N/A
  • Industry
  • STNE EDP Services
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STNE Technology
  • KRYS Health Care
  • Exchange
  • STNE Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • STNE 3.6B
  • KRYS 3.6B
  • IPO Year
  • STNE 2018
  • KRYS 2017
  • Fundamental
  • Price
  • STNE $14.52
  • KRYS $133.05
  • Analyst Decision
  • STNE Buy
  • KRYS Strong Buy
  • Analyst Count
  • STNE 8
  • KRYS 8
  • Target Price
  • STNE $15.63
  • KRYS $211.13
  • AVG Volume (30 Days)
  • STNE 6.3M
  • KRYS 320.8K
  • Earning Date
  • STNE 08-13-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • STNE N/A
  • KRYS N/A
  • EPS Growth
  • STNE N/A
  • KRYS 109.01
  • EPS
  • STNE N/A
  • KRYS 4.16
  • Revenue
  • STNE $2,314,839,446.00
  • KRYS $333,448,000.00
  • Revenue This Year
  • STNE $24.50
  • KRYS $44.05
  • Revenue Next Year
  • STNE $7.81
  • KRYS $46.15
  • P/E Ratio
  • STNE N/A
  • KRYS $31.77
  • Revenue Growth
  • STNE 12.87
  • KRYS 247.53
  • 52 Week Low
  • STNE $7.72
  • KRYS $122.80
  • 52 Week High
  • STNE $15.27
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • STNE 57.60
  • KRYS 44.16
  • Support Level
  • STNE $13.52
  • KRYS $127.99
  • Resistance Level
  • STNE $15.27
  • KRYS $143.20
  • Average True Range (ATR)
  • STNE 0.62
  • KRYS 4.23
  • MACD
  • STNE 0.07
  • KRYS 1.01
  • Stochastic Oscillator
  • STNE 66.22
  • KRYS 44.48

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: